Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-26

Clinical Trial Update: Ventral Capsulotomy for Intractable OCD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for ventral capsulotomy as a treatment for intractable obsessive-compulsive disorder (OCD) is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Butler Hospital | Conditions: Obsessive-Compulsive Disorder | Phase 3 | Status: ENROLLING_BY_INVITATION